Brief: Optomed Q2 Adjusted EBITDA Turns To Loss At EUR 0.8 Mln

Optomed Oyj

04/08/2022 08:14

Aug 4 (Reuters) - Optomed Plc  OPTOMED.HE :
    * HALF-YEAR FINANCIAL REPORT, JANUARY - JUNE 2022
    * Q2 REVENUE DECREASED BY 7.0 PERCENT TO EUR 3,7 (4,0)
MILLION.
    * Q2 ADJUSTED EBITDA AMOUNTED TO EUR -813 (177) THOUSAND
CORRESPONDING TO -21.8 (4.4) PERCENT OF REVENUE
    * EXPECTS ITS FULL YEAR 2022 REVENUE TO GROW COMPARED TO
2021
    * US MARKET WILL BE CENTRIC FOR SUCCESS OF OPTOMED'S
STRATEGIC
GOALS AND REVENUE GROWTH FOR NEXT FIVE YEARS
    * Q2 AND THEREFORE ALSO FIRST HALF OF YEAR WERE WEAK, AS
PREVIOUSLY PREDICTED, CAUSED BY DECREASE IN REVENUE FROM CHINA.
    * NEAR FUTURE LOOKS STRONG DUE TO RAPID GROWTH FROM WESTERN
MARKETS AND UPCOMING NEW PRODUCT LAUNCHES, SUCH AS AURORA AEYE,
ARE EXPECTED TO ACCELERATE GROWTH IN COMING YEARS.
    * WE MAINTAIN OUR CURRENT FULL YEAR OUTLOOK, BUT DESPITE OUR
SUCCESS IN WESTERN MARKETS, CHINESE MARKET STILL CAUSES
UNCERTAINTY OVER FULL YEAR REVENUE

Source text for Eikon:  ID:nWkr2cKby4 
Further company coverage:  OPTOMED.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))